Trial Profile
Open-label pilot study on the effect of Bosentan on trophic skin lesion in the diabetic fOOT Syndrome.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Oct 2022
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Diabetic foot
- Focus Adverse reactions
- Acronyms BOOTS
- 30 May 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 22 Feb 2012 New trial record